Dilemmas and limitations interpreting carbohydrate antigen 19-9 elevation after curative pancreatic surgery: A case report

Introduction: Serum carbohydrate antigen 19-9 (CA19-9) is routinely used in the management of pancreatic cancer for diagnosis, prognostication and surveillance purposes despite its low specificity. Case presentation: This case report demonstrates the challenges of interpreting elevated serum CA19.9...

Descripción completa

Detalles Bibliográficos
Autores principales: Gold, Grace, Goh, Su Kah, Christophi, Christopher, Muralidharan, Vijayaragavan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280008/
https://www.ncbi.nlm.nih.gov/pubmed/30513493
http://dx.doi.org/10.1016/j.ijscr.2018.11.022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280008/
https://www.ncbi.nlm.nih.gov/pubmed/30513493
http://dx.doi.org/10.1016/j.ijscr.2018.11.022

Ejemplares similares